According to Sellas Life Sciences's latest financial reports the company has -$7.98 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $4.85 M | -76.16% |
2021-12-31 | $20.34 M | -27.23% |
2020-12-31 | $27.96 M | 358.9% |
2019-12-31 | $6.09 M | 16.17% |
2018-12-31 | $5.24 M | 153.38% |
2017-12-31 | $2.07 M | -141.42% |
2016-12-31 | $-5 M | -136.98% |
2015-12-31 | $13.51 M | -63.54% |
2014-12-31 | $37.05 M | 529.61% |
2013-12-31 | $5.88 M | -78.79% |
2012-12-31 | $27.75 M | 174.49% |
2011-12-31 | $10.11 M | 316.13% |
2010-12-31 | $2.43 M | 227.94% |
2009-12-31 | $0.74 M | -91.74% |
2008-12-31 | $8.96 M | -17.14% |
2007-12-31 | $10.82 M | 541050% |
2006-12-31 | $0 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.22 B | -2,909.53% | ๐บ๐ธ USA |